Thursday, June 28, 2012

Gemmus Pharma Gets Series A

San Francisco-based Gemmus Pharma, a developer of treatments for influenza, said today that it has raised a Series A funding. Size of the round was not disclosed. The round was led by Life Science Angels, and also included BlueTree Allied Angels, Tech Coast Angels, Wilmington Investor Network and The Angels Forum. Gemmus said the funds will go towards an IND filing for its therapy, which reduces symptoms during influenza infections. A recent regulatory filing indicates the firm is in the process of raising around $1.8M, with $1.45M already raised. More information »